Isomab Ltd
PrivateLast Round
Seed
Feb 20, 2024
Total Funding Raised
$10.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Isomab Ltd is a biotechnology company that develops isoform-specific antibody therapies for the treatment of cardiovascular and peripheral ischemic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Isomab Ltd Comparables
Compare Isomab Ltd with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Shanghai CirCode Biomed Co. Ltd. | 71% | |
| Ambulero, Inc. | 71% | |
| advanceCOR | 70% | |
Isomab Ltd Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Feb 20, 2024 |
Isomab Ltd Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SCVC | Seed |
| Mercia Ventures | Seed |
| Science Creates Ventures | Seed |
| Broadview Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 27, 2026
Grew 33% QoQ from 12 to 16 employees.
- May 19, 2026
Monthly visitors grew 221% MoM.
Isomab Ltd Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Isomab Ltd's valuation, stock price, and market status.